Eden Springs buys Swiss

The companies, Blue-Stream, AQA Coolers, Water Point and Nestle Direct Swiss, will be joined under one name - Eden Springs Swiss.

By MATTHEW KRIEGER
March 6, 2007 07:07

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Eden Springs, a joint venture of Mey Eden and Danona, said Monday it has acquired four Swiss companies for EURO9 million, increasing Eden Springs' share of the bottled water market in Switzerland to more than 70 percent. The companies, Blue-Stream, AQA Coolers, Water Point and Nestle Direct Swiss, will be joined under one name - Eden Springs Swiss. The President of Eden Springs, Ra'anan Zilberman, expects the company could earn over EURO14m. in 2007. He also said that, by establishing a new base in central Europe, Eden Springs would be able to improve its overall service across the continent. Eden Springs currently operates in 18 countries in Europe and employs over 2,000 people.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS